lenalidomide,daratumumab
janssen
nct02252172 : phase 3 - dara, lena &amp; dex vs len &amp; dex in previously untreated myeloma - maia study day2 exciting discussions #ims2022 induction for newly diagnosed #multiplemyeloma #mmsm #curemyeloma philippe moreau and team 
Multiple Myeloma Education Platform for Myeloma Community